The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations

  1. Mireia Seuma
  2. Andre Faure
  3. Marta Badia
  4. Ben Lehner  Is a corresponding author
  5. Benedetta Bolognesi  Is a corresponding author
  1. IBEC, Spain
  2. Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Spain

Abstract

Plaques of the amyloid beta (Aβ) peptide are a pathological hallmark of Alzheimer's Disease (AD), the most common form of dementia. Mutations in Aβ also cause familial forms of AD (fAD). Here we use deep mutational scanning to quantify the effects of >14,000 mutations on the aggregation of Aβ. The resulting genetic landscape reveals mechanistic insights into fibril nucleation, including the importance of charge and gatekeeper residues in the disordered region outside of the amyloid core in preventing nucleation. Strikingly, unlike computational predictors and previous measurements, the empirical nucleation scores accurately identify all known dominant fAD mutations in AB42, genetically validating that the mechanism of nucleation in a cell-based assay is likely to be very similar to the mechanism that causes the human disease. These results provide the first comprehensive atlas of how mutations alter the formation of any amyloid fibril and a resource for the interpretation of genetic variation in Aβ.

Data availability

Raw sequencing data and the processed data table (Supplementary file 3) have been deposited in NCBI's Gene Expression Omnibus (GEO) as record GSE151147. All code used for data analysis is available at https://github.com/BEBlab

The following data sets were generated

Article and author information

Author details

  1. Mireia Seuma

    IBEC, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  2. Andre Faure

    Systems Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4471-5994
  3. Marta Badia

    IBEC, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  4. Ben Lehner

    Systems Biology, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
    For correspondence
    ben.lehner@crg.eu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8817-1124
  5. Benedetta Bolognesi

    IBEC, Barcelona, Spain
    For correspondence
    bbolognesi@ibecbarcelona.eu
    Competing interests
    The authors declare that no competing interests exist.

Funding

Ministerio de Ciencia, Innovación y Universidades (RTI2018-101491-A-I00)

  • Benedetta Bolognesi

Ministerio de Ciencia, Innovación y Universidades (BFU2017-89488-P)

  • Ben Lehner

H2020 European Research Council (616434)

  • Ben Lehner

AGAUR (SGR 1322)

  • Ben Lehner

Agència de Gestió d'Ajuts Universitaris i de Recerca (2019FI_B 01311)

  • Mireia Seuma

Fondation Bettencourt Schueller (Prize)

  • Ben Lehner

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Seuma et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,355
    views
  • 698
    downloads
  • 36
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mireia Seuma
  2. Andre Faure
  3. Marta Badia
  4. Ben Lehner
  5. Benedetta Bolognesi
(2021)
The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations
eLife 10:e63364.
https://doi.org/10.7554/eLife.63364

Share this article

https://doi.org/10.7554/eLife.63364

Further reading

    1. Computational and Systems Biology
    Nobuhisa Umeki, Yoshiyuki Kabashima, Yasushi Sako
    Research Article

    The RAS-MAPK system plays an important role in regulating various cellular processes, including growth, differentiation, apoptosis, and transformation. Dysregulation of this system has been implicated in genetic diseases and cancers affecting diverse tissues. To better understand the regulation of this system, we employed information flow analysis based on transfer entropy (TE) between the activation dynamics of two key elements in cells stimulated with EGF: SOS, a guanine nucleotide exchanger for the small GTPase RAS, and RAF, a RAS effector serine/threonine kinase. TE analysis allows for model-free assessment of the timing, direction, and strength of the information flow regulating the system response. We detected significant amounts of TE in both directions between SOS and RAF, indicating feedback regulation. Importantly, the amount of TE did not simply follow the input dose or the intensity of the causal reaction, demonstrating the uniqueness of TE. TE analysis proposed regulatory networks containing multiple tracks and feedback loops and revealed temporal switching in the reaction pathway primarily responsible for reaction control. This proposal was confirmed by the effects of an MEK inhibitor on TE. Furthermore, TE analysis identified the functional disorder of a SOS mutation associated with Noonan syndrome, a human genetic disease, of which the pathogenic mechanism has not been precisely known yet. TE assessment holds significant promise as a model-free analysis method of reaction networks in molecular pharmacology and pathology.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Eric V Strobl, Eric Gamazon
    Research Article

    Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.